GBI Data API provides standardized and custom APIs for GBI's global pharmaceutical data, covering drugs, clinical trials, registration applications, market access, and HCPs. Companies can integrate the data into CRM systems, enterprise data platforms, BI dashboards, Agent platforms, and other business systems for automated synchronization, unified management, and continuous updates.
Internal systems lack authoritative data
Enterprise data platforms, BI reports, and business systems contain proprietary operational data but lack authoritative external information on global pipelines, clinical trials, regulatory registration, market access, and HCPs. Frequent manual searches and data preparation consume time and make it difficult to establish a unified data environment.
Internal and external data use inconsistent definitions
Drug, company, and institution data use different field names and reporting definitions across internal and external sources, with no shared primary keys. Cleaning and mapping are costly, and integrated analysis remains difficult even after ingestion.
Keeping data current is difficult
Companies often rely on manual research or periodic data purchases, resulting in long update cycles and outdated information. This makes it difficult to capture key changes promptly and reduces the efficiency of market monitoring, competitive analysis, and business decision-making.
GBI Data API opens GBI's authoritative pharmaceutical databases through standardized interfaces covering drug pipelines, clinical trials, registration applications, centralized procurement and tendering, reimbursement access, and HCPs. Consistent field definitions, unified entity identifiers, and incremental updates enable companies to synchronize authoritative external data automatically with their enterprise data platforms, BI systems, and business applications. Authentic, real-time, traceable data continuously enriches enterprise data assets to support ongoing market monitoring, reporting, analysis, and decision-making.
Drawing on GBI's extensive global pharmaceutical databases, the service covers drugs, clinical trials, registration applications, market access, HCPs, healthcare institutions, scientific publications, and clinical guidelines. A unified, trusted data source reduces the cost of manual research and data preparation.
GBI OneID assigns unique identifiers to core entities such as drugs, companies, institutions, and HCPs, precisely linking external industry data with internal CRM, sales, medical affairs, and marketing data. It helps companies break down data silos and establish a unified data foundation for analysis and applications across systems and business workflows.
Standard and custom API services support both rapid integration and bespoke development. Automated collection, professional data cleansing, and continuous updates maintain data accuracy, timeliness, and stability. Field extensions, data processing, and dedicated API customization help meet each company's specific business and digital transformation needs.
GBI Health unites global pharmaceutical data, AI capabilities and industry expertise to deliver future-ready solutions across the entire product lifecycle.
Contact Us
